A matter of heart: The general practitioner consultation in an evidence-based world

Scandinavian Journal of Primary Health Care

Volumn 21, Issue 1, 2003, Pages 3-9

  Getz, Linn ^a,b   Nilsson, Peter M ^c   Hetlevik, Irene ^d  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Concept of risk; Emotional health; Ethics; Evidence based medicine; General practice; Human sciences; Risk perception; Unrecognised myocardial infarction

Indexed keywords

BIOMEDICINE; CONFERENCE PAPER; CONSULTATION; EMOTIONAL STABILITY; ETHICS; EVIDENCE BASED MEDICINE; EXPERIENCE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEART INFARCTION; MEDICAL DECISION MAKING; PERCEPTION; PRIMARY MEDICAL CARE;

AGED; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH STATUS INDICATORS; HUMANS; MALE; MYOCARDIAL INFARCTION; NORWAY; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SELF CONCEPT; STRESS, PSYCHOLOGICAL;

EID: 0037353281     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/02813430310000483     Document Type: Conference Paper

References (50)

1. Willenheimer R. Statistical significance versus clinical relevance in cardiovascular medicine. Prog Cardiovasc Dis 2001;44:155-67.
2. Kannel WB, Abbott RD. Incidence and prognosis of unrecognised myocardial infarction. An update on the Framingham study. N Engl J Med 1984;311:1144-7.
3. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Heart Protection Study Collaborative Group. Lancet 2002;360:7-22.
4. Yusuf S. Two decades of progress in preventing vascular disease. Lancet 2002;360:2-3.
5. Wilhelmsen L, Pyörälä K, Wedel H, Cook T, Pedersen T, Kjekshus J. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J 2001;22:1119-27.
6. Nilsson PM, Brandström H, Lingfors H, Israelsson B, Hedbäck B, Sjöberg G, et al. Gender differences in secondary prevention of coronary heart disease: reasons to worry or not? Scand J Prim Health Care 2003;21:37-42.
7. Nationella riktlinjer för kranskärlsjukdom (National guidelines for treatment of ischaemic heart disease). Stockholm: Socialstyrelsen, 2000.
8. Behandling av hyperlipidemi (Treatment of hyperlipidaemia). Uppsala: Läkemedelsverket, 1999 (revision 2002).
9. Marteau TM, Kinmonth AL. Screening for cardiovascular risk: public health imperative or matter for individual informed choice? BMJ 2002;325:78-80.
10. Prevention of coronary risk in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Summary of recommendations. Eur Heart J 1998;19:1434-503.
11. Elwyn G, Gwyn R. Narrative-based medicine - stories we hear and stories we tell: Analysing talk in clinical practice. BMJ 1999;318:186-8.
12. Greenhalgh T. Narrative-based medicine: narrative-based medicine in an evidence-based world. BMJ 1999;318:323-5.
13. Price J, Leaver L. ABC of psychological medicine: Beginning treatment. BMJ 2002;325:33-5.
14. Reis S, Hermoni D, Livingstone P, Borkan J. Integrated narrative and evidence-based case report: case report of paroxysmal atrial fibrillation and anticoagulation. BMJ 2002;325:1018-20.
15. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann Intern Med 2002;136:471-6.
16. Sackett DL. The arrogance of preventive medicine. CMAJ 2002;167:363-4.
17. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study. Ann Intern Med 1995;122:96-102.
18. Sheifer SE, Gersh BJ, Yanez ND, Ades PA, Burke GL, Manolio TA. Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarctions in the elderly. J Am Coll Cardiol 2000;35:119-26.
19. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med 2001;135:801-11.
20. Meland E, Ellekjær H, Gjelsvik B, Kimsås A, Holmen J, Hetlevik I. Medikamentell forebygging av hjerte- og karsykdommer i allmennpraksis (Pharmacological prevention of cardiovascular diseases in general practice). Tidsskr Nor Lægeforen 2000;120:2643-7.
21. Skjervheim H. Det instrumentalistiske mistaket. I: Mennesket. Filosofisk Essayistikk (The instrumentalistic mistake. In: Man. Philosophical essays). Oslo: Universitetsforlaget, 2002.
22. Hofmann B. On the value-ladenness of technology in medicine. Med Health Care Philos 2001;4:335-46.
23. Brindle P, May M. The prediction of coronary heart disease risk in individuals: an imprecise science. Int J Epidemiol 2002;31:822-4.
24. Lupton D. Risk. London: Routledge, 1999.
25. Swensen E. Diagnose: Risiko (Diagnosis: Risk). Oslo: Universitetsforlaget, 2000.
26. Reventlow S, Charlotte AC, Tulinius C. "In really great danger..." The concept of risk in general practice. Scand J Prim Health Care 2001;19:71-5.
27. Skolbekken JA. The risk epidemic in medical journals. Soc Sci Med 1995;40:291-5.
28. Skolbekken JA. Communicating the risk reduction achieved by cholesterol reducing drugs. BMJ 1998;316:1956-8.
29. Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 2001;10(Suppl 1):19-13.
30. Misselbrook D, Armstrong D. Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract 2001;51:276-9.
31. Ogden J. Psychosocial theory and the creation of the risky self. Soc Sci Med 1995;40:409-15.
32. Andersen J. No går det på helsa laus. Helse, sykdom og risiko for sykdom i to nord-norske kystsamfunn ("Now it has become a health threat". Health, disease and risk for disease in two coastal communities in northern Norway) [dissertation]. Tromsø: University of Tromsø, Institutt for sosiologi og institiutt for samfunnsmedisin, 1998.
33. Kenen RH. The at-risk health status and technology: a diagnostic invitation and the 'gift' of knowing. Soc Sci Med 1996;42:1545-53.
34. Williams R, Kiecolt-Glaser J, Legato MJ, Ornish D, Powell LH, Syme SL, et al. The impact of emotions on cardiovascular health. J Gend Specif Med 1999;2:52-8.
35. Ornish D. Dean Ornish, MD: a conversation with the editor. Interview by William Clifford Roberts. Am J Cardiol 2002;90:271-98.
36. Welin C, Lappas G, Wilhelmsen L. Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med 2000;247:629-39.
37. Sheps DS, Sheffield D. Depression, anxiety, and the cardiovascular system: the cardiologist's perspective. J Clin Psychiatry 2001;62(Suppl 8):12-6.
38. Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 2000;35:561-7.
39. Everson SA, Kaplan GA, Goldberg DE, Salonen R, Salonen JT. Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol 1997;17:1490-5.
40. Moller L, Kristensen TS, Hollnagel H. Self-rated health as a predictor of coronary heart disease in Copenhagen, Denmark. J Epidemiol Community Health 1996;50:423-8.
41. Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 1997;38:21-37.
42. Maruta T, Colligan RC, Malinchoc M, Offord KP. Optimism-pessimism assessed in the 1960s and self-reported health status 30 years later. Mayo Clinic Proc 2002;77:748-53.
43. Foucault M. The birth of the clinic. An archeology of medical perception. NY: Vintage Books, 1994.
44. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-42.
45. Getz L, Kirkengen AL. Ultrasound screening in pregnancy: Advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas. Soc Sci Med. In press.
46. Freeman AC, Sweeney K. Why general practitioners do not implement evidence: a qualitative study. BMJ 2001;323:1100-2.
47. Hetlevik I. The role of clinical guidelines in cardiovascular risk intervention in general practice [dissertation]. Trondheim: Trondheim University, Bjaerum, 1999.
48. Haynes B. Clinical expertise in the area of evidence-based medicine and patient choice. ACP J Club 2002;136:A11-4.
49. Kirkengen AL. Medisinen, postmodernismen og slutten på vissheten (Medicine, post-modernism and the end of certainty). Nytt norsk tidsskrift 3/1998;281-6.
50. Hollnagel H, Malterud K. From risk factors to health resources in medical practice. Med Health Care Philos 2000;3:257-64.